Clinical Trial Update: Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)

View source ↗

Summary

A non-interventional study (URBAN) evaluated obinutuzumab for untreated follicular lymphoma and has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Gazyva (Obinutuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Follicular Lymphoma | Status: COMPLETED | Results posted: 2025-05-09